-+ 0.00%
-+ 0.00%
-+ 0.00%

UNITED THERAPEUTICS CORP - ADVANCE OUTCOMES PHASE 3 STUDY OF RALINEPAG IN PAH MEETS PRIMARY AND SECONDARY ENDPOINTS

Reuters·07/29/2026 10:32:46

Please log in to view news